Short answer = No.
Long answer =
In Kaur v London Borough of Ealing [2008] EWHC 2062 (Admin) Moses LJ (sitting at first instance) stated at paragraph 22:
"An Authority is only entitled to depart from the statutory code for reasons which are clear and cogent (see R(Munjaz) v Mersey Care NHS Trust [2006] 2 AC 148). I suggest that that is sufficient authority also for the proposition that any authority would have to justify its departure from the non-statutory guide."
So doctors can deviate from statutory guidance provided that they have good reason to do so, and record that reason.
Doctors have to have due regard to guidance produced by the National Institute for Clinical and Health Excellence (NICE). Once NICE guidance is published, health professionals are expected to take it fully into account when exercising their clinical judgment. However, NICE guidance does not override the individual responsibility of health professionals to make appropriate decisions according to the circumstances of the individual patient in consultation with the patient and/or their guardian/carer.
In particular, guidance that does not recommend a treatment or procedure, or that recommends its use only in defined circumstances, is not the same as a ban on that treatment or procedure being provided by the NHS. (Such as the so called ban on T3). If, having considered the guidance, a health professional considers that the treatment or procedure would be the appropriate option in a given case, there is no legal bar on the professional recommending the treatment or on the NHS funding it.
Is the statement from the British Thyroid Association national guidance that doctors have to have due regard to?
The BTA published a statement (NB the BTA have been very careful not to call it Guidance or Guidelines) to support their laboratory blood test approach. It is only 10 pages long and is not supported by a great deal of evidence. Further, it does not meet the criteria laid out in Ali v London Borough of Newham 2012.
In that case, the Judge said that in order to ascertain the weight that should be given to particular guidance it is necessary to give due regard to:
- the authorship of the guidance,
- the quality and intensity of the work done in the production of the guidance,
- the extent to which the (possibly competing) interests of those who are likely to be affected by the guidance have been recognised and weighed,
- the importance of any more general public policy that the guidance has sought to promote,
and
- the express terms of the guidance itself.
The author of the Guidance is the British Thyroid Association.
The BTA is “A non profit making Learned Society, membership of the BTA is restricted to professional clinical specialist doctors, retired consultants, academics, scientists, trainees, nurses and medical students in the UK who manage patients with thyroid disease and/or are researching into the thyroid and its disease in humans.” british-thyroid-association...
The BTA is not a Public Body. It is not included in the list of public bodies that the Freedom of Information Act applies to. The statement has not been required to be produced by an Act of Parliament or Regulations made under any Act of Parliament. There is no statute to require health professionals to have due regard to the statement.
Therefore the statement is not statutory guidance.
The BTA is not a Royal College, Royal Institution Chartered Institute or Regulator.
The BTA is not a Professional Body. It does not have a Code of Conduct, which if members breach, requires their expulsion from the body. A doctor does not require membership of a BTA register to call him/her self an Endocrinologist or Thyroidologist. Membership is gained by completing a form, being proposed and seconded by existing members and paying a fee, currently £55 for joint membership with the British Thyroid Foundation.
The BTA has not been charged by a Public Body to produce any guidance.
The BTA is simply an association of people.
The BTA did not consult real patient organisations; just organisations they have a close connection to. This in turn presents an appearance of bias. The case of Lawal v Northern Spirit Ltd
[2004] 1 All ER 187 said that if in the view of a fair-minded and informed observer there was a
real possibility of subconscious bias, the case should be dismissed. With such close relationships with the BTF and the Society for Endocrinology, a fair-minded and informed observer would form the view that there was a
real possibility of subconscious (or conscious) bias to the endorsements of the statement and consequently cannot be relied on.
The express terms of the statement only refer to "primary hypothyroidism", yet doctors use it as if it is about all form of thyroid problems such as:
- poor T4 to T3 conversion,
- excessive rT3 production,
- T3 resistance at the cell membrane
- T3 resistance at the nuclear membrane
etc..
In short, the statement does not carry weight and more importantly it is not logical. To use the BTA statement for all thyroid problems, let alone "primary hypothyroidism" is not logical. The Bolitho v City and Hackney Health Authority 1997 case requires doctors to carry out a course of action that is logical or face legal action for negligence.
Doctors do not have to comply with the BTA statement, they should not use it to withhold treatment or reduce a patient's dose. In fact, if they do, they could be negligent and face court action.